“To ask the Secretary of State for Health and Social Care when he expects the Medicines and Healthcare products Regulatory Agency will make public their decision on licensing the personalised immunotherapy developed to treat the malignant brain tumour glioblastoma, DCVax-L.”
“To ask the Secretary of State for Health and Social Care whether his Department plans to work with the National Institute for Health and Care Excellence to expedite market access to the personalised immunotherapy developed to treat the malignant brain tumour glioblastoma DCVax-L via the NHS.”
Market Data 
Markets 
AI
